WeVote
Log In

Bill

Bill

HB 3326

Relating to dental care for seniors; prescribing an effective date.

2025 Regular Session Introduced by Cyrus Javadi and 2 co-sponsors

Metra trains must carry naloxone, store it accessibly, and train staff to administer; provides civil immunity for good-faith responders, effective Jan 1, 2027.

In committee upon adjournment.
0
WeVote Research Nonpartisan
Bill Summary · HB 3326

Summary — HB 3326 (Metra — Naloxone Requirement)

Status: Introduced Feb 18, 2025 by Rep. Martha Deuter. Passed the House (May 2, 2025); received from the House (May 5, 2025). Re-referred under Rule 19(a) to the Rules Committee. Effective date if enacted: January 1, 2027.

Purpose

Require commuter rail trains operated under the Regional Transportation Authority (the Commuter Rail Board, commonly Metra) to carry an opioid antagonist (e.g., naloxone) and to protect trained personnel who administer it from civil liability when acting in good faith, in order to improve emergency response to opioid overdoses aboard trains.

Key provisions

  • Adds Section 3B.09d to the Regional Transportation Authority Act (70 ILCS 3615/3B.09d):
    • All Commuter Rail Board trains must carry naloxone or another opioid antagonist while in operation.
    • The opioid antagonist must be stored in easily accessible locations throughout train cars.
    • Only train conductors or other individuals who are trained in the use and administration of opioid antagonists may administer the medication.
    • The Commuter Rail Board shall adopt rules to implement these requirements (rulemaking for storage, inventory, training, and operational procedures).
  • Adds Section 37 to the Good Samaritan Act (745 ILCS 49/37 new):
    • Provides civil immunity for a Commuter Rail Board train conductor or other trained individual who in good faith dispenses or administers an opioid antagonist under the new RTA provision.
    • Immunity does not apply for acts that constitute willful or wanton misconduct.
    • The term “opioid antagonist” references the definition in Section 5‑23 of the Substance Use Disorder Act.

Who is affected

  • Primary: Commuter Rail Board (Metra) operations and staff — requirements for carrying naloxone, storing it accessibly, training personnel, and adopting implementing rules.
  • Secondary: Train conductors and other employees authorized to administer the medication (training and scope of practice).
  • Public: Commuter rail passengers — potential increase in life-saving responses to opioid overdoses aboard trains.
  • Legal: Extends Good Samaritan-style immunity to qualifying conduct by trained rail personnel.

Implementation and timeline

  • Agency rulemaking required by the Commuter Rail Board to operationalize storage, inventory control, training standards, and administration protocols.
  • Effective January 1, 2027 if enacted — allows time for procurement and training.

Considerations

  • Costs and logistics: acquiring supply, storage solutions, restocking, and training programs will create operational costs for the Commuter Rail Board (not specified in the bill).
  • Scope of administration limited to trained personnel; bystanders are not authorized to administer under this statute.
  • Liability protection is limited to good‑faith acts and excludes willful or wanton misconduct.

Statutory citations added: 70 ILCS 3615/3B.09d (Regional Transportation Authority Act) and 745 ILCS 49/37 (Good Samaritan Act).

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.